Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By End-use (Medical, Personal Use), By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global cannabidiol market size was exhibited at USD 5.19 billion in 2022 and is projected to hit around USD 28.92 billion by 2032, growing at a CAGR of 16.9% during the forecast period 2023 to 2032.

cannabidiol market size

Key Pointers:

  • The marijuana segment dominated the market and accounted for a revenue share of over 51.0% in 2022.
  • The Business to Business (B2B) segment dominated the market and accounted for a revenue share of over 52.1% in 2022.
  • In B2B end use, the pharmaceuticals sub-segment dominated the market and accounted for a revenue share of over 71.0% in 2022.
  • In 2022, North America dominated the market with a revenue share of over 86.0% and will continue to retain its leading position in the market. 
  • In 2022, the medical end-use segment accounted for the largest revenue share owing to the rising use of cannabis derivatives for various medical conditions.
  • North America accounted for the largest revenue share in 2022 and is expected to maintain its lead over the forecast period. Favorable regulations, increasing awareness about CBD oil, growing consumer preference, and a rise in the number of manufacturers are the factors expected to fuel market growth in the region

Cannabidiol Market Report Scope

Report Coverage Details
Market Size in 2023 USD 9.15 Billion
Market Size by 2032 USD 13.16 Billion
Growth Rate from 2023 to 2032 CAGR of 4.12%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Source type, sales type, end-use, region
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

 

Increasing awareness regarding the health benefits of cannabidiol (CBD), changing consumer opinion, and the attitude toward CBD products are some of the key factors driving the demand for these products. Cannabidiol is a chemical compound that is found in the cannabis Sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high CBD content. The cannabis Sativa plant has over 80 chemicals that are identified as cannabinoids. Out of all the chemicals, cannabidiol is most widely used for medical purposes due to its lack of psychoactive effect. 

Cannabidiol oil is used in various medical applications to treat disorders including anxiety and depression and is also used for stress relief, cancer symptom relief, inflammation, and diabetes prevention. The recent COVID-19 pandemic has affected many industries around the world, including the CBD industry. The impact of COVID-19 has led to disruption in production processes. Due to strict quarantine measures taken across the globe, there is a stagnation in the supply of products, including CBD products. In addition, most of the retail stores are currently closed due to the pandemic. Hence, the marketplace may face a slowdown amidst the pandemic, however, it can gain momentum in 2021 due to the increase in demand for CBD-based products in the coming years. 

The global market is expected to develop at a lucrative rate over the forecast period owing to the increased acceptance of CBD-based products to treat diseases. There is a growing need for nutrient-rich foods to help people achieve fitness objectives and avoid problems such as inflammation and pain. Furthermore, the Center for Food Safety (CFS) assesses companies that sell CBD-based products based on their manufacturing process, processing procedures, testing processes, and customer openness. Such government activities piqued consumer interest, resulting in increased uptake of CBD-based products. 

The introduction of CBD-infused goods is a priority for major industry players. CBD oil is a non-psychoactive and legal component of hemp that can be used in a variety of industries, including food, health products, pharmaceuticals, and cosmetics. To capture a large revenue share in the CBD market, the industry players are expected to use organic and inorganic methods such as mergers, acquisitions, and new product introduction. In June 2021, Vertical Wellness announced that it has agreed to merge with CanaFarma Hemp Products Corp., a Canada-based company that offers multiple products and services related to hemp. After the merger, Vertical Wellness, a U.S.-based cannabidiol company, would transform into a public entity with a combined worth of USD 50 million. 

Some of the prominent players in the Cannabidiol Market include:

  • ENDOCA
  • Cannoid, LLC
  • Medical Marijuana, Inc.
  • Folium Biosciences
  • Elixinol
  • NuLeaf Naturals, LLC
  • Isodiol International, Inc.
  • Pharmahemp d.o.o.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global cannabidiol market.

By Source Type 

  • Hemp
  • Marijuana

By Sales Type 

  • B2B
    • By End-use
      • Pharmaceuticals
      • Wellness
        • Food & Beverages
        • Personal Care & Cosmetics
        • Nutraceuticals
        • Others
  • B2C
    • By Sales Channel
      • Hospital Pharmacies
      • Online
      • Retail Stores
  • By End-use
    • Medical
      • Chronic Pain
      • Mental Disorders
      • Cancer
      • Others
    • Personal Use

By End-use 

  • Medical
    • Chronic Pain
    • Mental Disorders
    • Cancer
    • Others
  • Personal Use
  • Pharmaceuticals
  • Wellness
    • Food & Beverages
    • Personal Care & Cosmetics
    • Nutraceuticals
    • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global cannabidiol market size was exhibited at USD 5.19 billion in 2022 and is projected to hit around USD 28.92 billion by 2032

The global cannabidiol market is growing at a compound annual growth rate (CAGR) of 16.9% from 2023 to 2032.

Marijuana segment dominated the CBD market and accounted for a revenue share of over 71.0% in 2022. This is attributable to the high availability of marijuana-derived products in dispensaries, government-approved pharmacies, and stores.

Some key players operating in the CBD market include ENDOCA; Isodiol International, Inc.; Medical Marijuana, Inc.; Cannoid, LLC; Elixinol; Folium Biosciences; NuLeaf Naturals, LLC; and Pharmahemp d.o.o.

Key factors that are driving the CBD market growth include increasing demand for cannabidiol (CBD) for medical and wellness purposes owing to its healing properties.

Chapter 1. Introduction
                   1.1 Research Methodology
                       1.1.1 Information procurement
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation
                       1.3.1 Region Market: CAGR Calculation
                   1.4 Region Based Segment Share Calculation
                   1.5 List of Secondary Sources
                   1.6 List of Primary Sources
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 CBD Market Variables, Trends & Scope
                   3.1 Market Segmentation (Global Cannabidiol (CBD) Market)
                   3.2 Global Cannabis Extracts Trade Route
                   3.3 Global Cannabis Extracts Demand and Supply Analysis
                   3.4 Penetration & Growth Prospects Mapping
                   3.5 Cannabis Regulatory Scenario, By Country
                       3.5.1 U.S.
                           3.5.1.1 Cultivation/Production
                           3.5.1.2 Legal Status (CBD & THC)
                           3.5.1.3 Regulatory Bodies Involved
                       3.5.2 Canada
                           3.5.2.1 Cultivation
                           3.5.2.2 Production
                           3.5.2.3 Legal Status (CBD & THC)
                           3.5.2.4 Regulatory Bodies Involved
                       3.5.3 Germany
                           3.5.3.1 Cultivation/Production
                           3.5.3.2 Legal Status (CBD & THC)
                           3.5.3.3 Regulatory Bodies Involved
                       3.5.4 Italy
                           3.5.4.1 Cultivation
                           3.5.4.2 Production
                           3.5.4.3 Legal Status (CBD & THC)
                           3.5.4.4 Regulatory Bodies Involved
                       3.5.5 Croatia
                           3.5.5.1 Cultivation/Production
                           3.5.5.2 Legal Status (CBD & THC)
                           3.5.5.3 Regulatory Bodies Involved
                       3.5.6 Netherlands
                           3.5.6.1 Cultivation
                           3.5.6.2 Production
                           3.5.6.3 Legal Status (CBD & THC)
                           3.5.6.4 Regulatory Bodies Involved
                       3.5.7 Czech Republic
                           3.5.7.1 Cultivation/Production
                           3.5.7.2 Legal Status (CBD & THC)
                       3.5.8 Poland
                           3.5.8.1 Cultivation/Production
                           3.5.8.2 Legal Status (CBD & THC)
                           3.5.8.3 Regulatory Bodies Involved
                       3.5.9 Switzerland
                           3.5.9.1 Cultivation/Production
                           3.5.9.2 Legal Status (CBD & THC)
                           3.5.9.3 Regulatory Bodies Involved
                       3.5.10 Australia
                           3.5.10.1 Cultivation/Production
                           3.5.10.2 Legal Status (CBD & THC)
                           3.5.10.3 Regulatory Bodies Involved
                       3.5.11 Israel
                           3.5.11.1 Cultivation/Production
                           3.5.11.2 Legal Status (CBD & THC)
                           3.5.11.3 Regulatory Bodies Involved
                       3.5.12 Ururguay
                           3.5.12.1 Cultivation/Production
                           3.5.12.2 Legal Status (CBD & THC)
                           3.5.12.3 Regulatory Bodies Involved
                       3.5.13 Colombia
                           3.5.13.1 Cultivation/Production
                           3.5.13.2 Legal Status (CBD & THC)
                           3.5.13.3 Regulatory Bodies Involved
                       3.5.14 Argentina
                           3.5.14.1 Cultivation/Production
                           3.5.14.2 Legal Status (CBD & THC)
                           3.5.14.3 Regulatory Bodies Involved
                       3.5.15 Chile
                           3.5.15.1 Cultivation/Production
                           3.5.15.2 Legal Status (CBD & THC)
                           3.5.15.3 Regulatory Bodies Involved
                   3.6 Market Dynamics
                       3.6.1 Market Driver Analysis
                           3.6.1.1 Growing legalization of cannabis-based CBD products
                           3.6.1.2 Increasing preference toward cannabis extracts such as oils and tinctures
                           3.6.1.3 Growing adoption of CBD-based products for treating various medical conditions
                           3.6.1.4 Rise in the number of retailers selling CBD-based products
                       3.6.2 Market Restraint Analysis
                           3.6.2.1 Stringent government regulations
                           3.6.2.2 Absence of legalization programs in several Asian and African countries
                           3.6.2.3 High cost of CBD in leading markets
                       3.6.3 Industry Challenges
                   3.7 Cannabidiol (CBD) - Porter’s Analysis
                       3.7.1 Threat of New Entrants
                       3.7.2 Bargaining Power of Buyers
                       3.7.3 Competitive Rivalry
                       3.7.4 Bargaining Power of Suppliers
                       3.7.5 Threat of Substitutes
                   3.8 Cannabidiol (CBD) - PESTEL Analysis
                       3.8.1 Political
                       3.8.2 Environmental
                       3.8.3 Social
                       3.8.4 Technology
                       3.8.5 Legal
                       3.8.6 Economic
                   3.9 Opportunity Analysis
                   3.10 Import/Export Scenario, by Country
                       3.10.1 U.S.
                       3.10.2 Canada
                           3.10.2.1 Import
                           3.10.2.2 Export
                       3.10.3 Germany
                       3.10.4 Italy
                       3.10.5 France
                       3.10.6 Croatia
                       3.10.7 Netherlands
                       3.10.8 Czech Republic
                       3.10.9 Poland
                       3.10.10 Switzerland
                       3.10.11 Uruguay
                       3.10.12 Columbia
                       3.10.13 Brazil
                       3.10.14 Argentina
                       3.10.15 Chile
                       3.10.16 Australia
                       3.10.17 China
                       3.10.18 India
                       3.10.19 Japan
                       3.10.20 New Zealand
                       3.10.21 South Korea
                       3.10.22 South Africa
                       3.10.23 Israel
                   3.11 Product Adoption Pattern Analysis
                   3.12 Value Chain Analysis
                       3.12.1 Raw Material Trends
                           3.12.1.1 Market price evolution of biomass commodity cost (to processor)
                           3.12.1.2 Manufacturing Trends
                   3.13 Average Selling Price of Cannabidiol, by Country
                   3.14 Key End Users
                       3.14.1 U.S. Market Scenario
                   3.15 COVID-19 Impact Analysis
Chapter 4 Cannabidiol (CBD) Market: Source Type Estimates & Trend Analysis
                   4.1 Cannabidiol (CBD) Market Size & Forecasts And Trend Analysis By Source Type, 2023 - 2032,
                       4.1.1 Hemp
                           4.1.1.1 Hemp CBD market estimates and forecasts, 2023 - 2032
                       4.1.2 Marijuana
                           4.1.2.1 Marijuana CBD market estimates and forecasts, 2023 - 2032
Chapter 5 Cannabidiol (CBD) Market: Sales Type Estimates & Trend Analysis
                   5.1 Cannabidiol (CBD) Market, By Sales Type Analysis
                   5.2 Business to Business (B2B)
                       5.2.1 Business to Business (B2B) market estimates and forecasts, 2023 - 2032
                   5.3 Business to Consumer (B2C)
                       5.3.1 Hospital Pharmacies
                           5.3.1.1 Hospital pharmacies market estimates and forecasts, 2023 - 2032
                       5.3.2 Online Stores
                           5.3.2.1 Online market estimates and forecasts, 2023 - 2032
                       5.3.3 Retail Stores
                           5.3.3.1 Retail stores market estimates and forecasts, 2023 - 2032
Chapter 6 Cannabidiol (CBD) Market: End-use Estimates & Trend Analysis
                   6.1 Cannabidiol (CBD) Market, By End-use Analysis
                   6.2 Medical
                       6.2.1 Chronic Pain
                           6.2.1.1 Chronic pain market estimates and forecasts, 2023 - 2032
                       6.2.2 Mental Disorders
                           6.2.2.1 Mental disorders market estimates and forecasts, 2023 - 2032
                       6.2.3 Cancer
                           6.2.3.1 Cancer market estimates and forecasts, 2023 - 2032
                       6.2.4 Others
                           6.2.4.1 Others market estimates and forecasts, 2023 - 2032
                   6.3 Personal Use
                       6.3.1 Personal Use market estimates and forecasts, 2023 - 2032
                   6.4 Pharmaceutical
                       6.4.1 Pharmaceutical CBD market estimates and forecasts, 2023 - 2032
                   6.5 Wellness
                       6.5.1 Food & Beverages
                           6.5.1.1 Food & beverages market estimates and forecasts, 2023 - 2032
                       6.5.2 Personal Care & Cosmetics
                           6.5.2.1 Personal care & cosmetics market estimates and forecasts, 2023 - 2032
                       6.5.3 Nutraceuticals
                           6.5.3.1 Nutraceuticals market estimates and forecasts, 2023 - 2032
                       6.5.4 Others
                           6.5.4.1 Other end-use market estimates and forecasts, 2023 - 2032
Chapter 7 Cannabidiol (CBD) Market: Regional Estimates & Trend Analysis
                   7.1 Global Cannabidiol Market Share, By Region, 2021 & 2032
                   7.2 North America
                       7.2.1 U.S.
                           7.2.1.1 U.S. CBD market estimates and forecasts, 2023 - 2032
                       7.2.2 Canada
                           7.2.2.1 Canada CBD market estimates and forecasts, 2023 - 2032
                   7.3 Europe
                       7.3.1 U.K.
                           7.3.1.1 U.K. CBD market estimates and forecasts, 2023 - 2032
                       7.3.2 Germany
                           7.3.2.1 Germany CBD market estimates and forecasts, 2023 - 2032
                       7.3.3 France
                           7.3.3.1 France CBD market estimates and forecasts, 2023 - 2032
                       7.3.4 Italy
                           7.3.4.1 Italy CBD market estimates and forecasts, 2023 - 2032
                       7.3.5 Netherlands
                           7.3.5.1 Netherlands CBD market estimates and forecasts, 2023 - 2032
                       7.3.6 Croatia
                           7.3.6.1 Croatia CBD market estimates and forecasts, 2023 - 2032
                       7.3.7 Poland
                           7.3.7.1 Poland CBD market estimates and forecasts, 2023 - 2032
                       7.3.8 Czech Republic
                           7.3.8.1 Czech Republic CBD market estimates and forecasts, 2023 - 2032
                       7.3.9 Switzerland
                           7.3.9.1 Switzerland CBD market estimates and forecasts, 2023 - 2032
                   7.4 Asia Pacific
                       7.4.1 Australia
                           7.4.1.1 Australia CBD market estimates and forecasts, 2023 - 2032
                       7.4.2 China
                           7.4.2.1 China CBD Market market estimates and forecasts, 2023 - 2032
                       7.4.3 India
                           7.4.3.1 India CBD Market market estimates and forecasts, 2023 - 2032
                       7.4.4 Japan
                           7.4.4.1 Japan CBD market estimates and forecasts, 2023 - 2032
                       7.4.5 New Zealand
                           7.4.5.1 New Zealand CBD market estimates and forecasts, 2023 - 2032
                       7.4.6 South Korea
                           7.4.6.1 South Korea CBD market estimates and forecasts, 2023 - 2032
                   7.5 Latin America
                       7.5.1 Brazil
                           7.5.1.1 Brazil CBD market estimates and forecasts, 2023 - 2032
                       7.5.2 Argentina
                           7.5.2.1 Argentina CBD market estimates and forecasts, 2023 - 2032
                       7.5.3 Colombia
                           7.5.3.1 Colombia CBD market estimates and forecasts, 2023 - 2032
                       7.5.4 Mexico
                           7.5.4.1 Mexico CBD market estimates and forecasts, 2023 - 2032
                       7.5.5 Uruguay
                           7.5.5.1 Uruguay CBD market estimates and forecasts, 2023 - 2032
                       7.5.6 Chile
                           7.5.6.1 Chile CBD market estimates and forecasts, 2023 - 2032
                   7.6 MEA
                       7.6.1 South Africa
                           7.6.1.1 South Africa CBD market estimates and forecasts, 2023 - 2032
                       7.6.2 Israel
                           7.6.2.1 Israel CBD market estimates and forecasts, 2023 - 2032
Chapter 8 Competitive Landscape
                   8.1 Company Profiles (Cannabis Companies)
                       8.1.1 Canopy Growth Corporation.
                           8.1.1.1 Company overview
                           8.1.1.2 Financial performance
                       8.1.2 Product Benchmarking
                           8.1.2.1 Strategic Initiatives
                       8.1.3 Aphria, Inc.
                           8.1.3.1 Company overview
                           8.1.3.2 Financial performance
                           8.1.3.3 Product Benchmarking
                           8.1.3.4 Strategic Initiatives
                       8.1.4 Aurora Cannabis
                           8.1.4.1 Company overview
                           8.1.4.2 Financial performance
                           8.1.4.3 Strategic initiatives
                       8.1.5 Maricann, Inc. (Wayland Group Corporation)
                           8.1.5.1 Company overview
                           8.1.5.2 Financial performance
                           8.1.5.3 Business strategies
                       8.1.6 Tilray
                           8.1.6.1 Company overview
                           8.1.6.2 Financial performance
                           8.1.6.3 Strategic Initiatives
                       8.1.7 GW Pharmaceuticals, plc
                           8.1.7.1 Company overview
                           8.1.7.2 Financial performance
                           8.1.7.3 Strategic Initiatives
                       8.1.8 ABcann Medicinals, Inc.
                           8.1.8.1 Company overview
                           8.1.8.2 Financial performance
                           8.1.8.3 Strategic Initiatives
                       8.1.9 Organigram Holding, Inc.
                           8.1.9.1 Company overview
                           8.1.9.2 Financial performance
                           8.1.9.3 Strategic Initiatives
                       8.1.10 Tikun Olam
                           8.1.10.1 Company overview
                           8.1.10.2 Strategic Initiatives
                       8.1.11 The Cronos Group
                           8.1.11.1 Company overview
                           8.1.11.2 Financial performance
                           8.1.11.3 Strategic Initiatives
                   8.2 Company Profiles (Cannabidiol Companies)
                       8.2.1 ENDOCA
                           8.2.1.1 Company Overview
                           8.2.1.2 Product Benchmarking
                           8.2.1.3 Strategic Initiatives
                       8.2.2 Isodiol International, Inc.
                           8.2.2.1 Company overview
                           8.2.2.2 Financial Performance
                           8.2.2.3 Product Benchmarking
                           8.2.2.4 Strategic Initiatives
                       8.2.3 MEDICAL MARIJUANA, INC.
                           8.2.3.1 company overview
                           8.2.3.2 Financial Performance
                           8.2.3.3 Product Benchmarking
                           8.2.3.4 Strategic Initiatives
                       8.2.4 Cannoid, LLC
                           8.2.4.1 Company Overview
                           8.2.4.2 Product Benchmarking
                       8.2.5 Elixinol
                           8.2.5.1 Company Overview
                           8.2.5.2 Product Benchmarking
                           8.2.5.3 Strategic Initiatives
                       8.2.6 Folium Biosciences
                           8.2.6.1 Company Overview
                           8.2.6.2 Product Benchmarking
                           8.2.6.3 Strategic Initiatives
                       8.2.7 NuLeaf Naturals, LLC
                           8.2.7.1 Company Overview
                           8.2.7.2 Product Benchmarking
                           8.2.7.3 Strategic Initiatives
                       8.2.8 Pharmahemp d.o.o.
                           8.2.8.1 Company Overview
                           8.2.8.2 Product Benchmarking

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert